Dr. Richard Tsong Lee, MD

Dr. Lee practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Lee's NPI, 1255503850, was assigned on March 24, 2008. Dr. Lee graduated from George Washington University School of Medicine and Health Sciences in 2001. Dr. Lee's California license number on file is A80861.

Dr. Lee's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Lee's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Lee to 1 more group practice or clinic, 1 other site and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lee is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lee's licenses on file in 4 states: California, Ohio, Texas and Illinois.

Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer and multiple myeloma among the conditions Dr. Lee treats.

CMS data shows 112 Medicare services from Dr. Lee across 5 procedure codes in 2024, all of them office visits, for 69 Medicare patients. Medicare paid $11,514 for them. Every service was in an office.

CMS counts 69 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 39 patients. 68% of them have cancer, and 68% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 66, with 69% women.

In 2024, Dr. Lee wrote 61 Medicare Part D claims for 19 patients. 61% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $483 in total drug cost. In 2021, CMS named 484 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

Dmand AI links 46 papers to Dr. Lee, published from 2008 to 2024. 2021 was the busiest year, with 7. The most frequent topics are Medical Oncology, Acupuncture Therapy and Antineoplastic Agents. Dr. Lee has published most often in Integr Cancer Ther. Dr. Lee's most frequent co-authors are Jennifer Leigh McQuade, MD, Eduardo D. Bruera, MD and Asrar A. Alahmadi, MD.

CMS Open Payments shows 76 general payments to Dr. Lee from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 69% of the total. Medtronic Vascular, Inc. paid the most, $1,189.

Dr. Lee graduated from George Washington University School of Medicine and Health Sciences in 2001. Dr. Lee is a member of ASCO and Society for Integrative Oncology.

Dr. Lee is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.